epidermolysis bullosa (EB) - Articles and news items

Abeona enrols first Phase 2 patient following successful Phase 1 Epidermolysis trial

Industry news / 27 September 2016 / Niamh Louise Marriott, Digital Content Producer

Also known as “Butterfly skin” syndrome, epidermolysis bullosa (EB) is a rare genetic skin disease that is caused by the absence of a gene (COL7A1)…

Abeona enrols 5th patient in gene therapy Epidermolysis Bullosa trial

Industry news / 16 September 2016 / Niamh Louise Marriott, Digital Content Producer

EB-101 is the company’s lead gene therapy program for patients suffering with recessive dystrophic epidermolysis bullosa (RDEB), a severe form of…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+